Topical Phytoterpenes for Plantar Fasciitis
Topical Phytoterpene Mixture for Treatment of Plantar Fasciitis in Adults
1 other identifier
interventional
42
1 country
1
Brief Summary
Randomized controlled trial of mixture of essential oils containing tea tree oil, rosemary, clove, pepper, in a formulation with skin permeation enhancers including limonene for the treatment of plantar fasciitis in adult men and women. Forty-two patients will be randomized to receive twice daily topical application of the treatment formulation or plain tea tree oil as a control. Analog pain scores will be assessed at the start of treatment and at two weeks. Analysis will be by student's T-test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 3, 2020
CompletedFirst Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
July 20, 2022
CompletedJuly 6, 2023
July 1, 2023
1.3 years
October 26, 2021
July 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Score Between Baseline and 2 Weeks
Patients will be asked to rate pain on a 1-10 analog scale at the start of the study and at 2 weeks
2 weeks
Study Arms (2)
Plain Tea Tree Oil Control
ACTIVE COMPARATORTopical application of 1ml 20% tea tree oil in almond oil base as a carrier twice daily for 2 weeks.
Verum
EXPERIMENTALTopical application twice daily of 1ml mixture for 2 weeks of essential oils containing tea tree oil, rosemary, clove, pepper, in a formulation with skin permeation enhancers including limonene.
Interventions
Eligibility Criteria
You may qualify if:
- Plantar fasciitis diagnosed by a medical practitioner and at least 3 months in duration
You may not qualify if:
- Age under 18 years, any history of diabetes, history of foot surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Biomedical Research,Inc.
Boise, Idaho, 83706, United States
Related Publications (1)
Burke BE, Baillie JE. Randomized placebo controlled trial of phytoterpenes in DMSO for the treatment of plantar fasciitis. Sci Rep. 2024 Jul 31;14(1):17621. doi: 10.1038/s41598-024-65979-1.
PMID: 39085322DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Briant Burke, MD
Center for Biomedical Research, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Identical bottles given to participants with serial number, aroma and feel of each treatment group is the same
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2021
First Posted
July 20, 2022
Study Start
January 15, 2019
Primary Completion
April 21, 2020
Study Completion
August 3, 2020
Last Updated
July 6, 2023
Record last verified: 2023-07